Steven D. Goldby

Steven D. Goldby has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Symyx Technologies Inc, Lifecore Biomedical, Inc. \DE\ and Accelrys, Inc. The record holds 153 filings, for trades running from 15 February 2006 to 23 May 2019.

The open-market side counts 1 purchase for €196k alongside 116 sales for €1.8M. On balance, insiders were net sellers of €1.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 15 share grants and 16 option exercises. In 2019 alone, the filings show 1 purchase and no sales.

On 30 May 2019 came the latest disclosure, an option exercise for €35k in Lifecore Biomedical, Inc. \DE\. The last purchase on record was published on 10 January 2019, which is 2,844 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.